SCHEMBL13692017

SCHEMBL13692017

CC(=O)Cn1ccc(-c2ccccc2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.45
KDM4E B2RXH2 3/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
NR2F2 P24468 1/20 0.43
CNR2 P34972 1/20 0.42
MAPT P10636 4/20 0.42
ALDH1A1 P00352 3/20 0.42
HPGD P15428 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.41
IDH1 O75874 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
AR P10275 1/20 0.37
AGTR1 P30556 1/20 0.37
LOXL2 Q9Y4K0 1/20 0.36
POLB P06746 1/20 0.36
CYP19A1 P11511 1/20 0.36
ABCC4 O15439 1/20 0.36
LMNA P02545 1/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1126991 0.85 AKR1B1 (0.61) AKR1B1KDM4ENPC1RAB9ANR2F2
SCHEMBL1126796 0.81 CNR2 (0.46) AKR1B1KDM4ENPC1RAB9ANR2F2
SCHEMBL1126874 0.79 CA12 (0.52) KDM4ERAB9AALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL1126850 0.76 SLC18A3 (0.45) KDM4ENPC1RAB9ANR2F2CNR2
SCHEMBL5870352 0.76 NTSR1 (0.40) AKR1B1KDM4ENPC1RAB9ANR2F2
SCHEMBL10911282 0.75 IDH1 (0.38) AKR1B1KDM4ENPC1RAB9ANR2F2
SCHEMBL12605596 0.75 ALDH1A1 (0.40) KDM4ENPC1RAB9ANR2F2MAPT
SCHEMBL1126872 0.72 CA12 (0.41) KDM4ENPC1RAB9ANR2F2ALDH1A1
Biphenyl SCHEMBL11131611 0.71 SMN1; SMN2 (0.64) KDM4ENPC1RAB9AMAPTALDH1A1
SCHEMBL1127117 0.70 KDM4E (0.39) KDM4ENPC1RAB9ANR2F2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090240058-A1 Activator for Peroxisome Proliferator-Activating Receptor Delta NIPPON CHEMIPHAR CO., LTD. (JP) 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090240058-A1 Activator for Peroxisome Proliferator-Activating Receptor Delta PPARG, PPARA, PPARD AKR1B1 1075/4885KDM4E 3267/4885NPC1 1565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.